Medical Developments International LimitedASX: MVP

Penthrox Regulatory Dossier accepted for review in Canada

· Issued by Medical Developments International Limited

Filed with ASX · · 2 pages · English

Penthrox Regulatory Dossier accepted for review in Canada Medical Developments International Limited (ASX: MVP) is delighted to announce that the regulatory dossier for Penthrox® submitted in Canada has now been accepted for review by the Canadian regulatory body, Health Canada. Accepting the MVP dossier for review, triggers a milestone payment of CAD$0.25 million from MVP’s partner, Purdue Pharma

Medical Developments International Limited on 6ix

Story so far

Earlier from Medical Developments International

Later from Medical Developments International

All Medical Developments International news releases